Results 201 to 210 of about 11,348,603 (380)
Cognitive‐behavioral group therapy versus phenelzine in social phobia: Long term outcome
Michael R. Liebowitz+11 more
openalex +1 more source
Does Cognitive-Behavioral Insomnia Therapy Alter Dysfunctional Beliefs About Sleep? [PDF]
Jack D. Edinger+4 more
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
Meta-anlaysis of Internet-based Behavior Therapy for Tic Disorder. [PDF]
Jo YD+9 more
europepmc +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
Obesity : Advances on diagnosis and treatment.4.Treatment of obesity.3.Behavior therapy.
坂田 利家
openalex +2 more sources
An Open Trial for Transdiagnostic Behavior Therapy for Primary Care (TBT-PC) in Veterans with Symptoms of Depression and Anxiety. [PDF]
Gros DF, Hart S, Pompei M, Acierno R.
europepmc +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source
Engaging the adolescent patients in the treatment of eating disorders: strategies and procedures of enhanced cognitive behavior therapy. [PDF]
Dalle Grave R, Calugi S.
europepmc +1 more source